The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart dis...

Por Athyros, V G, Mikhailidis, D P, Papageorgiou, A A, Symeonidis, A N, Pehlivanidis, A N, Bouloukos, V I, Elisaf, M
Publicado em 2004

A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes

Por Platzbecker, U, Symeonidis, A, Oliva, E N, Goede, J S, Delforge, M, Mayer, J, Slama, B, Badre, S, Gasal, E, Mehta, B, Franklin, J
Publicado no Leukemia (2017)

Poly (ADP-ribose) polymerase 1 mRNA levels strongly correlate with the prognosis of myelodysplastic syndromes

Por Diamantopoulos, P, Zervakis, K, Zervakis, P, Sofotasiou, M, Vassilakopoulos, T, Kotsianidis, I, Symeonidis, A, Pappa, V, Galanopoulos, A, Solomou, E, Kodandreopoulou, E, Papadopoulou, V, Korkolopoulou, P, Mantzourani, M, Kyriakakis, G, Viniou, N-A
Publicado no Blood Cancer J (2017)

Erythropoiesis‐stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower‐risk myelodysplastic syndrome

Por Garelius, H. K. G., Johnston, W. T., Smith, A. G., Park, S., de Swart, L., Fenaux, P., Symeonidis, A., Sanz, G., Čermák, J., Stauder, R., Malcovati, L., Mittelman, M., van de Loosdrecht, A. A., van Marrewijk, C. J., Bowen, D., Crouch, S., de Witte, T. J. M., Hellström‐Lindberg, E.
Publicado no J Intern Med (2016)